詹芸, 李瑞, 李晓琳, 韩燕星, 蒋建东*. 绿原酸通过IFN-γ信号通路抑制食管癌细胞中PD-L1的表达J. 药学学报, 2021,56(6): 1599-1605. doi: 10.16438/j.0513-4870.2021-0111
引用本文: 詹芸, 李瑞, 李晓琳, 韩燕星, 蒋建东*. 绿原酸通过IFN-γ信号通路抑制食管癌细胞中PD-L1的表达J. 药学学报, 2021,56(6): 1599-1605. doi: 10.16438/j.0513-4870.2021-0111
ZHAN Yun, LI Rui, LI Xiao-lin, HAN Yan-xing, JIANG Jian-dong*. Chlorogenic acid down-regulates the expression of PD-L1 in esophageal squamous cell carcinoma via IFN-γ signaling pathwayJ. Acta Pharmaceutica Sinica, 2021,56(6): 1599-1605. doi: 10.16438/j.0513-4870.2021-0111
Citation: ZHAN Yun, LI Rui, LI Xiao-lin, HAN Yan-xing, JIANG Jian-dong*. Chlorogenic acid down-regulates the expression of PD-L1 in esophageal squamous cell carcinoma via IFN-γ signaling pathwayJ. Acta Pharmaceutica Sinica, 2021,56(6): 1599-1605. doi: 10.16438/j.0513-4870.2021-0111

绿原酸通过IFN-γ信号通路抑制食管癌细胞中PD-L1的表达

Chlorogenic acid down-regulates the expression of PD-L1 in esophageal squamous cell carcinoma via IFN-γ signaling pathway

  • 摘要: 本研究应用体内、外模型探讨了绿原酸(chlorogenic acid,CGA)对食管癌中程序性死亡受体配体1(programmed cell death ligand 1,PD-L1)的表达调控作用,以及干扰素γ(interferon γ,IFN-γ)在这一调控过程中发挥的作用。遵从中国医学科学院药物研究所动物实验中心标准操作规程(SOP)建立小鼠食管癌模型,通过基因芯片检测发现小鼠食管癌组织中PD-L1的差异表达,并应用qRT-PCR、Western blot和免疫组化(immunohistochemistry,IHC)染色在小鼠食管癌组织中进行验证,然后在体外培养的食管癌细胞中进行进一步的验证和机制探讨。结果发现,CGA能够显著抑制小鼠食管癌组织中PD-L1的表达,但在体外培养的KYSE180及KYSE510食管癌细胞中,PD-L1的表达并不受CGA的调控。用IFN-γ对KYSE180和KYSE510细胞进行预处理,PD-L1的表达明显升高,再加入CGA处理,PD-L1的表达下调,并且随着CGA浓度的增加或者处理时间的延长,PD-L1表达受抑制的效果越明显。同时,通过对PD-L1上游的干扰素调节因子1(interferon regulatory factor 1,IRF1)的检测表明,在经IFN-γ预处理的KYSE180及KYSE510细胞中,IRF1的表达受到CGA的抑制,其变化趋势与PD-L1一致。上述结果表明,CGA可以通过IFN-γ信号通路下调食管癌中PD-L1的表达,为食管癌治疗的新方法提供了分子理论基础。

     

    Abstract: In this study, the regulatory effects of chlorogenic acid (CGA) on the expression of programmed cell death ligand 1 (PD-L1) in esophageal squamous cell carcinoma (ESCC), as well as the role of interferon γ (IFN-γ), has been discussed using both in vitro and in vivo animal models. ESCC murine model was established according to the standard operating procedures (SOP) of Animal Experiment Center of Institute of Materia Medica, Chinese Academy of Medical Sciences. The expression of PD-L1 in esophageal tissues of murine models was analyzed using the microarray assay. Then, the results were verified by qRT-PCR, Western blot and immunohistochemistry (IHC) staining, the molecular mechanism was explored in KYSE180 and KYSE510 ESCC cells in vitro. The results showed that CGA could suppress the expression of PD-L1 in tumor tissues in murine models significantly, rather than the expression in KYSE180 and KYSE510 ESCC cells in vitro. However, after the pretreatment of IFN-γ, the expression of PD-L1 was significantly increased, then it was down-regulated by CGA in both dose- and time-dependent manner. Meanwhile, the expression of interferon regulatory factor 1 (IRF1), an upstream regulatory factor of PD-L1, was suppressed by CGA in both KYSE180 and KYSE510 pretreated with IFN-γ, which was consistent with the expression of PD-L1. These results indicate that CGA down-regulates the expression of PD-L1 in ESCC via IFN-γ-IRF1 signaling pathway, providing the molecular theoretical basis for exploration of new treatment of ESCC.

     

/

返回文章
返回